| Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials | |
| Wang, Xiaotang; Qin, Dan; Liu, Yong; Lei, Runjia; Ren, Meixia; Wang, Runsheng; Wang, Ying | |
| 刊名 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
 |
| 2018 | |
| 卷号 | 11页码:11663-11672 |
| 关键词 | bevacizumab ranibizumab Neovascular age-related macular degeneration meta-analysis |
| ISSN号 | 1940-5901 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2912786 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Wang, Xiaotang,Qin, Dan,Liu, Yong,et al. Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2018,11:11663-11672. |
| APA | Wang, Xiaotang.,Qin, Dan.,Liu, Yong.,Lei, Runjia.,Ren, Meixia.,...&Wang, Ying.(2018).Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,11,11663-11672. |
| MLA | Wang, Xiaotang,et al."Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 11(2018):11663-11672. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论